Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Contacts
location
Phone number
Website URL
Similar Companies1000
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Novartis Venture Fund
Novartis Venture Fund is a private equity and venture capital arm of Novartis AG.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
BioMedPartners
BioMedPartners is a leading European venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Fountainhead Investment Partners
Fountainhead Investment Partners funds innovation in medical technologies and biologic sciences.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Financials
Investments111
Endogenex
Endogenex develops an endoscopic procedure to improve glycemic control in patients with Type 2 Diabetes.
Sector
Subsector
Location
total rounds
total raised
Zenas BioPharma
Zenas BioPharma develops immune-based therapies to transform patients' lives.
Sector
Subsector
Location
total rounds
total raised
Endeavor BioMedicines
Endeavor Biomedicines develops treatments targeting the underlying causes of pulmonary fibrosis.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits16
Solta Medical
Solta Medical is a California-based company that designs and manufactures energy-based medical device systems for aesthetic applications..
Sector
Subsector
Location
total rounds
total raised
Amunix
Amunix develops biologics to harness the immune system and conquer cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Amphora Medical
Amphora Medical develops medical devices and instruments.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders3
David Hirsch
David Hirsch is a founder and Managing Director of Longitude Capital. He focuses on investments in biotechnology. From 2005 to 2006, David Hirsch was a Vice President of Pequot Ventures where he worked in the life sciences practice. Prior to Pequot, David Hirsch was an Engagement Manager in the pharmaceutical practice of McKinsey & Company. While at McKinsey, he worked with many large pharmaceutical companies across a range of projects including clinical and commercial strategies, M&A evaluations, portfolio prioritization and managed care strategy. He currently serves on the boards of Civitas Therapeutics and Precision Therapeutics and is a board observer at InfaCare Pharmaceuticals and Xanodyne Pharmaceuticals. He is also actively involved with Longitude’s investments in Amarin (NASDAQ: AMRN) and Corcept Therapeutics (NASDAQ: CORT), as well as prior investments in Horizon Therapeutics and Sequenom (NASDAQ: SQNM).
current job
David Hirsch
Marc Galletti
Mr. Galletti is a Managing Director and Founder of Longitude Capital. Prior to Longitude Capital, Mr. Galletti was a Senior Vice President of Pequot Ventures, where he worked in the life sciences practice. Prior to Pequot Ventures, Mr. Galletti worked at Amerindo Investment Advisors, Vector Fund Management and the Global Healthcare Investment Banking Group at J.P. Morgan & Co. Mr. Galletti began his career in the life sciences industry at APM, a management consultancy dedicated to improving operations performance within the patient care and procedural units of large acute-care hospitals. Mr. Galletti currently serves on the boards of Amphora Medical and Murj. He has previously served on the boards of Aptus Endosystems (acquired by Medtronic) and Twelve (acquired by Medtronic) and has also been involved with prior investments in Ablation Frontiers (acquired by Medtronic), MAP Pharmaceuticals (MAPP, acquired by Allergan), Prestwick Pharmaceuticals (acquired by Ovation), Sadra Medical (acquired by Boston Scientific), and Threshold Pharmaceuticals (THLD). Mr. Galletti sits or has sat on advisory boards for the Innovation and New Ventures Office at Northwestern University, the Program for Biomedical Engineering at Brown University, the Venture Capital Advisory Board of AdvaMed and the Life Sciences Advisory Board of Silicon Valley Bank. Mr. Galletti holds an M.B.A. in Finance and Health Services Management from the Kellogg School of Management at Northwestern University and an A.B. from Princeton University.
current job
Marc Galletti
Patrick Enright
Patrick Enright is the Board Member at Esperion Therapeutics.He has served as a Member Of Board Of Directors since April 2013.He is also the Managing Director, Longitude Capital Management Co., LLC. Patrick is a founder of Longitude Capital Management Co., LLC, a venture capital firm focused on investments in biotechnology, and has served as its Managing Director since 2007. From 2002 through 2006, Patrick was a Managing Director of Pequot Ventures where he co-led the life sciences investment practice. Prior to Pequot, Patrick was a Managing Member responsible for the Delta Opportunity Fund, where he invested in privately held and publicly traded biotechnology companies. Patrick is a director of a number of companies including,Corcept Therapeutics, Inc. (NASDAQ: CORT),Jazz Pharmaceuticals plc (NASDAQ: JAZZ).Patrick earned an M.B.A. from the Wharton School of Business at the University of Pennsylvania.B.S. in Biological Sciences from Stanford University.
current job
Patrick Enright
Employee Profiles39
Activity
Recent News10
The graph reveals the ratio (%) of positive news articles in a chosen time range